Insider Trading February 26, 2026

ReposiTrak CEO's Pre-Set Plan Yields $62,891 in Stock Sales

Randall K. Fields' RK Fields Charitable 2022, LLC disposes of 7,500 shares as company updates dividend, repurchase program, and product initiatives

By Avery Klein TRAK
ReposiTrak CEO's Pre-Set Plan Yields $62,891 in Stock Sales
TRAK

ReposiTrak Chief Executive Officer Randall K. Fields sold 7,500 shares of common stock across February 24 and 25, 2026, through a pre-arranged Rule 10b5-1 plan, generating $62,891 in proceeds. The transactions were reported on a Form 4 filing with the SEC. The company has also declared a quarterly dividend, authorized a new 10b5-1 buyback allocation, disclosed a patent-pending traceability technology, and broadened a partnership with the National Grocers Association.

Key Points

  • CEO Randall K. Fields sold 7,500 shares on Feb 24-25, 2026 under a Rule 10b5-1 plan, generating $62,891.
  • RK Fields Charitable 2022, LLC directly owns 100,000 shares after the sale; Fields retains multiple indirect holdings including common and Series B preferred shares via related entities.
  • Company actions include a quarterly $0.02 per share dividend, a new $2 million 10b5-1 repurchase authorization within a $21 million program, a patent-pending traceability correction technology, and an expanded partnership with the National Grocers Association.

ReposiTrak, Inc. (NASDAQ:TRAK) reported insider sales by Chief Executive Officer Randall K. Fields, who disposed of 7,500 shares of common stock on February 24 and 25, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The trades were carried out under a pre-established Rule 10b5-1 trading plan and produced total proceeds of $62,891.

On February 24, Fields sold 2,200 shares at a weighted average price of $8.5026, with execution prices spanning $8.385 to $8.58. The following day, February 25, another 5,300 shares were sold at a weighted average price of $8.3369, with individual sale prices ranging from $8.15 to $8.52. The filing lists RK Fields Charitable 2022, LLC as the seller.

After these transactions, RK Fields Charitable 2022, LLC is recorded as directly owning 100,000 shares of ReposiTrak. In addition to those holdings, the filing shows that Fields maintains multiple indirect ownership positions: 3,483,955 shares in total, including 615,260 shares held through Riverview Financial Corp, 30,667 shares attributed to Spouse, and 333,643 shares held via Fields Management, Inc. The filing further discloses indirect ownership of preferred securities, namely 169,797 shares of Series B Preferred Stock through Riverview Financial Corp and 3,704 shares of Series B Preferred Stock by Spouse.

Market context included in the report notes that TRAK shares have fallen 53% over the past year and were trading at $8.87 at the time of the notice. An InvestingPro analysis cited in the filing indicates the stock appears undervalued at current levels and references 13 additional ProTips plus a Pro Research Report for further company analysis.

Separately, corporate actions disclosed by ReposiTrak include the declaration of a quarterly dividend of $0.02 per share, equating to an annualized rate of $0.08 per share. The dividend is to be payable to shareholders of record as of December 31, 2025, with payment expected around February 13, 2025.

The company also announced a new 10b5-1 share repurchase program authorizing the buyback of up to $2 million of common stock. This authorization is part of a larger $21 million share repurchase program, of which $7.6 million remained available for repurchases as of December 1, 2025, according to the disclosure.

On the product and partnership front, ReposiTrak said it has developed a patent-pending technology designed to automatically detect and correct errors in food traceability data. The company framed the innovation as addressing a sector challenge it described as a 40% error rate in traceability records. In addition, ReposiTrak reported an expansion of its strategic partnership with the National Grocers Association to support traceability compliance management for independent grocers through education, training, and resources intended to improve financial performance and manage regulatory pressures.


Clear summary

ReposiTrak CEO Randall K. Fields sold 7,500 shares under a Rule 10b5-1 plan on February 24 and 25, 2026, generating $62,891. The seller was RK Fields Charitable 2022, LLC, which now directly holds 100,000 shares. The company also disclosed dividend details, a targeted 10b5-1 buyback authorization within a broader repurchase program, a patent-pending traceability correction technology, and an expanded partnership with the National Grocers Association. TRAK shares have declined 53% over the past year and traded at $8.87 at the time of the report.

Key points

  • Insider sale: 7,500 shares sold under a Rule 10b5-1 trading plan on Feb 24-25, 2026, producing $62,891 in proceeds; RK Fields Charitable 2022, LLC listed as the seller.
  • Ownership snapshot: RK Fields Charitable 2022, LLC owns 100,000 shares directly; Fields maintains multiple indirect holdings including common and Series B preferred stock through various entities.
  • Corporate actions and product news: quarterly dividend of $0.02 per share declared; a new $2 million 10b5-1 repurchase authorization added to a $21 million program with $7.6 million available as of Dec 1, 2025; a patent-pending data correction tool and expanded National Grocers Association partnership disclosed.

Risks and uncertainties

  • Share price volatility - TRAK has fallen 53% over the prior 12 months, which may affect investor sentiment and market valuation.
  • Limited repurchase capacity - while a new $2 million 10b5-1 authorization was announced, only $7.6 million remained available from the broader $21 million program as of Dec 1, 2025.
  • Traceability error exposure - the company cited a 40% error rate in traceability records as an industry challenge that its patent-pending technology is intended to address, indicating ongoing operational data quality risks for the sector.

This article presents the filing and corporate disclosures as reported and does not provide investment advice.

Risks

  • Share price decline - TRAK shares have dropped 53% over the past year, reflecting volatility and potential valuation concerns.
  • Limited buyback capacity - $7.6 million remained available for repurchases from the broader $21 million program as of Dec 1, 2025, which constrains repurchase flexibility.
  • Traceability data issues - the company cites a 40% error rate in traceability records as an industry challenge, indicating operational and compliance risk for food traceability systems.

More from Insider Trading

Powell Industries Insider Sells $828,905 of Stock Across Two Days Feb 26, 2026 iRhythm Officer Sells $1.2M in Stock as Company Posts Strong Q4 and 2026 Outlook Feb 26, 2026 Oceaneering Accounting Chief Sells $341,581 in Stock as Shares Trade Near Yearly High Feb 26, 2026 iRhythm CFO Disposes $702,553 in Stock After Performance-Based Grant Vesting Feb 26, 2026 Vertex Pharmaceuticals SVP Disposes of $108,456 in Company Stock Feb 26, 2026